Use of a Functional Neuroimaging Battery for the Evaluation of a Meditation Retreat (FETZER)

Thomas Jefferson University

Status

Completed

Conditions

Healthy

Treatments

Other: Meditation Retreat

Study type

Observational

Funder types

Other

Identifiers

NCT02443766

11G.488

Details and patient eligibility

About

Over 2 decades scientists have been studying the effect on brain function from meditation practices. The purpose of this study is to measure the effect of a meditation retreat program on serotonin and dopamine transporter binding and changes in cerebral blood flow. The retreat program that will be followed is a week-long retreat called the Ignatian Retreat.

Full description

This study will utilize DaTscan single photon emission computed tomography (SPECT) and functional magnetic resonance imaging (fMRI) in healthy subjects within one month of entering the retreat. The study uses DaTscan to measure the effect on serotonin and dopamine transporter binding, and functional magnetic resonance imaging (fMRI) to measure the effect on cerebral blood flow. The Ignatian Retreat is a weeklong retreat which involves meditation and prayer.

Additionally, study participants will complete a variety of questionnaires and scales to measure psychological and spirituality states. The scans and questionnaires will be completed before and after the participant has completed the retreat. The ultimate goal of the study is to analyze and compare pre and post imaging and neuropsychological and spirituality changes in healthy controls who participate in this retreat.

Enrollment

14 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Able to give informed consent and willing to complete the study.
Willing to undergo the full imaging procedures.
Women of childbearing potential with a negative serum pregnancy test.

Exclusion criteria

Any neurological or psychiatric disorders, including drug or alcohol abuse, that may interfere with cerebral blood flow as determined by the principal investigator.
Any medical conditions that may interfere with cerebral blood flow as determined by the principal investigator.
Currently taking medication that might affect cerebral blood flow (i.e. antidepressants, antipsychotics, anxiolytics, benzodiazepines, sedatives, antiseizure medications)
Subject is unable or unwilling to lie still in the scanner (i.e. due to claustrophobia or weight > 350 pounds)
Subject has metal in their body or other reason that they cannot undergo magnetic resonance imaging.
Previous brain surgery or intracranial abnormalities they may complicate interpretation of the brain scans. (e.g. stroke, tumor, vascular abnormality).
Pregnancy
Allergy to iodine or shellfish.
Concurrent participation in another research protocol that might affect the outcome of this study as determined by the principle Investigator.